Lana Medical Company

SASE:9587 Stock Report

Market Cap: ر.س154.4m

Lana Medical Management

Management criteria checks 2/4

Lana Medical's CEO is Salman Saleh Al Fawzan, appointed in Sep 2020, has a tenure of 4.33 years. directly owns 18.4% of the company’s shares, worth SAR28.42M. The average tenure of the management team and the board of directors is 4.3 years and 4.3 years respectively.

Key information

Salman Saleh Al Fawzan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.3yrs
CEO ownership18.4%
Management average tenure4.3yrs
Board average tenure4.3yrs

Recent management updates

Recent updates


CEO

Salman Saleh Al Fawzan (49 yo)

4.3yrs

Tenure

Mr. Salman Saleh Ibrahim Al Fawzan is CEO & Executive Director of Lana Medical Company from September 24, 2020.


Leadership Team

NamePositionTenureCompensationOwnership
Salman Saleh Al Fawzan
CEO & Executive Director4.3yrsno data18.4%
SAR 28.4m
Muhammad Abdul Karim Al-Matroudi
Sales Manager & Secretary of the Board4.3yrsno datano data
Abdullah Abdul Aziz Abdul Al-Qaseer
Director of Human Resources3.4yrsno datano data

4.3yrs

Average Tenure

33yo

Average Age

Experienced Management: 9587's management team is considered experienced (4.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Salman Saleh Al Fawzan
CEO & Executive Director4.3yrsno data18.4%
SAR 28.4m
Abdul Rahman Abdul Mohsen Al Mansour
Non-Executive Independent Director4.3yrsno datano data
Mohammed Abdullah Al Shiha
Chairman4.3yrsno data20%
SAR 30.9m
Khaled Bin Saleh Ibrahim Al Fawzan
Vice Chairman4.3yrsno data18.4%
SAR 28.4m

4.3yrs

Average Tenure

55yo

Average Age

Experienced Board: 9587's board of directors are considered experienced (4.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 08:17
End of Day Share Price 2025/01/02 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lana Medical Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution